Figure 1 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models ‌ Isabel Quiros-Gonzalez (14952835)

“…<b>B,</b> Survival curves for control (Ctrl) and bevacizumab (Bev)-treated groups in MCF7 tumor-bearing mice (top, <i>n</i>_mice = 4 Ctrl; <i>n</i>_mice = 4 Bev) and MDA-MB-231 tumor-bearing mice (bottom, <i>n</i>_mice = 8 Ctrl; <i>n</i>_mice = 11 Bev). <b>C,</b> Estimated average tumor growth per group for the control group and the bevacizumab-treated group of MDA-MB-231 mice (<i>n</i>_tumors = 14 Ctrl; <i>n</i>_tumors = 20 Bev), illustrating the durable response obtained in the subset of the treated group denoted as responders (Bev-R) compared with nonresponders (Bev-NR) based on their tumor growth rates (see Supplementary Data). …”